期刊文献+

血清胱抑素C水平与不同糖耐量患者颈动脉粥样硬化的相关性研究 被引量:1

Correlation of serum cystatin C with carotid atherosclerosis in populations of different glucose tolerance
下载PDF
导出
摘要 目的探讨血清胱抑素C(Cys C)水平与不同糖耐量患者颈动脉粥样硬化的相关性。方法选取糖耐量正常者(NGT组)30例、糖耐量异常患者(IGT组)60例、新诊断2型糖尿病患者(T2DM组)60例,检测3组受试者血生化指标及血清Cys C水平,用超声检测颈动脉内膜中层厚度(IMT)。结果 3组受试者血清Cys C水平及颈动脉IMT逐渐增高,组间两两比较差异有统计学意义(P<0.05)。多元Logistic回归分析显示,血清Cys C、高敏C反应蛋白(hs-CRP)、胰岛素抵抗指数(HOMA-IR)和低密度脂蛋白(LDL-C)是颈动脉粥样硬化的独立危险因素。结论糖代谢异常早期即存在高血清Cys C水平,并参与了糖尿病动脉硬化的进程。 Objective To investigate the changes of serum cystatin C levels in different glucose tolerance patients,as well as the correlation of these changes with carotid atherosclerosis. Methods 150 people were divided into 3 groups includ-ing normal glucose tolerance group (NGT group,n=30),impaired glucose tolerance group (IGT group,n=60) and newly diag-nosed type 2 diabetes mellitus group (T2DM group,n=60). Serum cystatin C,carotid intima-media thickness and other indicators were tested and analyzed. Results Serum cystatin C levels and carotid intima-media thickness were gradually increased in 3 groups,with significant differences between any two groups (P&lt;0.05). Multiple Logistic regression analysis showed that serum cystatin C,high sensitive C-reactive protein (hs-CRP),HOMA-IR and LDL-C were independently associated with carotid atherosclerosis. Conclusion Cystatin C plays an important role in diabetic arteriosclerosis during its progression.
出处 《中国现代医药杂志》 2014年第3期13-15,共3页 Modern Medicine Journal of China
关键词 糖耐量异常 2型糖尿病 高敏C反应蛋白 颈动脉粥样硬化 胱抑素C Impaired glucose tolerance Type 2 diabetes mellitus Cystatin C High sensitive C-reactive protein Carotid atherosclerosis
  • 相关文献

参考文献7

  • 1Kasami R, Kaneto H, Katakami N,et al. Relationship between carotid intima-media thickness and the presence and extent of coronary stenosis in type 2 diabetic patients with carotid atheroselerosis but without history of coronary artery disease. Di- abetes Care, 2011,34 : 468-470. 被引量:1
  • 2Ogawa Y,Goto T,Tamasawa N,et al. Serum cystatin C in diabetic patients.Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy. Diabetes Res Clin Pract, 2008,79 : 357-361. 被引量:1
  • 3金启辉,鲍晓峰,谷卫.胱抑素C与早期2型糖尿病患者颈动脉内膜中层厚度的相关性[J].中华内分泌代谢杂志,2012,28(1):29-31. 被引量:26
  • 4Eriksson P,Deguchi H,Samnegard A,et al. Human evidence that the eystatin C gene is implicated in focal progression of coronary artery disease. Arterioseler Thromb Vasc Biol,2004,24:551~557. 被引量:1
  • 5Sukhova GK,Wang B,Libby P,et al. Cystatin C deficiency in- creases elastic lamina degradation and aortic dilatation in apolipopmein in E-nullmice.Cric Res, 2005,96 : 368-375. 被引量:1
  • 6张安吉,王海昌,李成祥.血清胱抑素C水平与冠状动脉狭窄程度的关系研究[J].实用医学杂志,2010,26(21):3943-3945. 被引量:12
  • 7Tsai HT,Wang PH,Tee YT,et al. Imbalanced serum concentra- tion between cathepsin B and cystatin C in patients with pelvic inflammatory disease.Fertil Steril, 2009,91 : 549-555. 被引量:1

二级参考文献25

  • 1郭立新,潘琦,初明峰,郭发金,孙明晓,李慧,李铭,刘小萍.高同型半胱氨酸血症与糖尿病患者颈动脉内膜中层厚度关系及强化控制的影响[J].中华内分泌代谢杂志,2006,22(1):19-22. 被引量:51
  • 2卢曙芳,沈建国,朱麒钱,官莉莉.2型糖尿病患者颈动脉内膜中层厚度与细胞间黏附分子1、C反应蛋白的相关性[J].中华内分泌代谢杂志,2006,22(4):358-359. 被引量:20
  • 3Simonsen O, Grubb A, Thysell H.The blood serum concentration of Cystatin C (gamma-trace)as a measure of the glomerular filtration rate [J]. Scand J Clin Lab Invest, 1985,45(2):97- 101. 被引量:1
  • 4Shi G P, Sukhova G K, Grubb A, et al. Cystatin c deficiency in human atherosclerosis and aortic aneurysms [Jl. Clin Invest, 1999,104(9) : 1191-1197. 被引量:1
  • 5Sukhova G K, wang B, Libby P, et al. cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice [J]. Circ Res, 2005,96(3) :368- 75. 被引量:1
  • 6Eriksson P, Deguchi H, Samnegard A, et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease [J]. Arterioscler Thromb Vase Biol, 2004,24(3) : 551-557. 被引量:1
  • 7Loew M, Hoffmann M M, Koenig W, et al. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events [J]. Arterioscler Thromb Vasc Biol, 2005,25(7) : 1470-1474. 被引量:1
  • 8Pinon P, Kaski J C. Inflammation, atherosclerosis and cardiovascular disease risk:PAPP-A,Lp-PLA2 and cystatin C. New insights or redundant information [J]? Rev Esp Cardiol, 2006,59 (3) : 247-258. 被引量:1
  • 9Bengtsson E,Fong To,Grubb A, et al. Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE2defieient mice [J]. Atherosclerosis, 2005,180( 1 ) :45-53. 被引量:1
  • 10Arpegard J,Ostergren J,de Faire U,et al.Cystatin C a marker of peripheral atherosclerotic disease.Atherosclerosis,2008,199:397-401. 被引量:1

共引文献34

同被引文献17

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部